Skip to main content

Table 2 Color doppler ultrasound and blood flow index (based on Lee’s classification)

From: Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies

Variable

Lee’s classification (I-V) (n = 75a)

p value

I

(n = 19)

II

(n = 13)

III

(n = 26)

IV

(n = 14)

V

(n = 3)

Cortical thickness1ab (cm)

1.5 ± 0.3

1.5 ± 0.2

1.5 ± 0.2

1.6 ± 0.3

1.5 ± 0.2

0.40

Cortical thickness2bc (cm)

1.7 ± 0.6

1.5 ± 0.3

1.5 ± 0.3

1.5 ± 0.3

1.3 ± 0.2

0.59

Change in cortical thicknesscd (cm)

−0.1 ± 0.6

0.1 ± 0.4

0 ± 0.2

0.1 ± 0.3

0.2 ± 0.1

0.23

Echo enhancement (%)

2 (10.5)

1 (7.7)

2 (7.7)

8 (57.1)

2 (66.7)

< 0.01

Blood flow distribution1 (I-V)

4.9 ± 0.3

4.8 ± 0.4

4.9 ± 0.3

4.9 ± 0.4

5.0 ± 0

0.96

Blood flow distribution2 (I-V)

4.8 ± 0.4

4.6 ± 0.6

4.7 ± 0.5

4.4 ± 0.7

3.7 ± 1.1

0.06

Change in blood flow distribution (I-V)

0.5 ± 0.2

0.2 ± 0.4

0.1 ± 0.4

0.5 ± 0.8

1.3 ± 1.1

0.02

MRA

 

 Vs1 (cm/s)

91.7 ± 20.0

109.4 ± 46.6

102.1 ± 26.8

100.1 ± 30.7

133.6 ± 45.7

0.31

 Vs2 (cm/s)

104.6 ± 54.1

114.8 ± 48.3

117.2 ± 49.1

82.2 ± 32.1

95.4 ± 35.2

0.20

 Vs1- Vs2 (cm/s)

−12.9 ± 61.1

−5.4 ± 26.7

−15.1 ± 51.4

17.9 ± 24.6

38.3 ± 10.5

0.04

 RI1

0.6 ± 0.1

0.7 ± 0.1

0.7 ± 0.1

0.7 ± 0.1

0.6 ± 0

0.80

 RI2

0.7 ± 0.1

0.7 ± 0.1

0.7 ± 0.1

0.7 ± 0.1

0.7 ± 0

0.36

 RI1/RI2

1.0 ± 0.2

1.0 ± 0.1

1.0 ± 0.1

0.9 ± 0.1

0.9 ± 0.1

0.15

SRA

 Vs1 (cm/s)

54.2 ± 17.4

59.0 ± 18.1

55.3 ± 14.7

61.6 ± 19.0

81.3 ± 2.1

0.14

 Vs2 (cm/s)

53.1 ± 15.1

60.6 ± 18.8

56.6 ± 13.0

52.4 ± 21.4

45.5 ± 3.5

0.38

 Vs1- Vs2 (cm/s)

1.1 ± 20.8

−1.6 ± 12.6

−1.3 ± 17.7

9.1 ± 23.6

35.8 ± 5.3

0.05

 RI1

0.6 ± 0.1

0.6 ± 0.1

0.6 ± 0.1

0.6 ± 0.1

0.6 ± 0.1

0.66

 RI2

0.6 ± 0.1

0.6 ± 0

0.6 ± 0.1

0.7 ± 0.1

0.7 ± 0.1

0.15

 RI1/RI2

1.0 ± 0.1

1.0 ± 0.1

1.0 ± 0.1

0.9 ± 0.1

0.9 ± 0.1

0.18

IRA

 Vs1 (cm/s)

29.4 ± 8.0

34.5 ± 9.1

31.2 ± 8.0

34.2 ± 9.1

37.4 ± 10.7

0.26

 Vs2 (cm/s)

31.2 ± 10.3

34.5 ± 7.5

32.7 ± 8.5

28.6 ± 10.9

28.5 ± 10.5

0.42

 Vs1- Vs2 (cm/s)

−1.8 ± 11.4

0 ± 9.3

−1.5 ± 10.2

5.6 ± 9.3

8.8 ± 8.3

0.10

 RI1

0.6 ± 0.1

0.6 ± 0.1

0.6 ± 0.1

0.6 ± 0

0.6 ± 0

0.92

 RI2

0.6 ± 0.1

0.6 ± 0.1

0.6 ± 0.1

0.6 ± 0.1

0.7 ± 0

0.11

RI1/RI2

1.0 ± 0.2

1.0 ± 0.1

1.0 ± 0.1

0.9 ± 0.1

0.9 ± 0

0.08

ARA

 Vs1 (cm/s)

20.8 ± 6.7

21.6 ± 4.4

19.7 ± 5.3

25.3 ± 7.2

27.4 ± 6.2

0.07

 Vs2 (cm/s)

20.2 ± 8.0

22.1 ± 8.2

20.9 ± 9.5

18.9 ± 8.0

19.6 ± 4.5

0.79

 Vs1- Vs2 (cm/s)

0.6 ± 7.3

−0.5 ± 9.3

−1.2 ± 13.0

6.4 ± 9.1

7.8 ± 1.8

0.07

 RI1

0.6 ± 0

0.6 ± 0

0.6 ± 0.1

0.6 ± 0

0.6 ± 0

0.85

 RI2

0.6 ± 0.1

0.6 ± 0.1

0.6 ± 0.1

0.6 ± 0.1

0.7 ± 0.1

0.04

 RI1/RI2

1.0 ± 0.1

1.0 ± 0.1

1.1 ± 0.2

1.0 ± 0.1

0.9 ± 0

0.04

  1. ain total series, 27 cases without complete ultrasonic data
  2. bthe baseline level at the time when patients had the lowest sCr level after transplantation, the same definition for following index
  3. cthe level at the time of biospy, the same definition for following index
  4. dthe change from baseline level to the level at the time of biospy, the same definition for following index